Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer

Evotec SE has announced the appointment of Dr. Ingrid Müller as Chief Operating Officer, effective May 1, 2026. Dr. Müller brings over 20 years of international leadership experience in life sciences, focusing on operations, strategy, supply, procurement, and R&D integration. As COO, she will oversee global operations and the implementation of the Horizon initiative, emphasizing quality, productivity, scalability, and cost efficiency.

CEO Dr. Christian Wojczewski highlighted Dr. Müller’s strategic and operational expertise, which will contribute to Evotec's growth transformation efforts. Previously, she strengthened supply resilience and supported growth at companies like CureVac, Sanofi, and Fresenius Kabi.

Dr. Müller expressed her commitment to enhancing operational excellence and supporting Evotec's sustainable growth. Her new role is expected to further strengthen the company's technological and scientific capabilities.